Testosterone enanthate (CHEM035998)

IdentificationTaxonomyBiological PropertiesPhysical PropertiesToxicity ProfileSpectraConcentrationsLinksReferencesXML
Record Information
Version1.0
Creation Date2016-05-26 07:08:44 UTC
Update Date2016-11-09 01:21:25 UTC
Accession NumberCHEM035998
Identification
Common NameTestosterone enanthate
ClassSmall Molecule
Description
Contaminant Sources
  • FooDB Chemicals
Contaminant TypeNot Available
Chemical Structure
Thumb
MOLSDFPDBSMILESInChI
Synonyms
ValueSource
17-((1-Oxoheptyl)oxy)androst-4-en-3-oneChEBI
17-Hydroxyandrost-4-en-3-one, 17-heptanoateChEBI
17beta-Hydroxyandrost-4-en-3-one heptanoateChEBI
Testosterone 17-enanthateChEBI
Testosterone heptanoateChEBI
DelatestrylKegg
17-Hydroxyandrost-4-en-3-one, 17-heptanoic acidGenerator
17b-Hydroxyandrost-4-en-3-one heptanoateGenerator
17b-Hydroxyandrost-4-en-3-one heptanoic acidGenerator
17beta-Hydroxyandrost-4-en-3-one heptanoic acidGenerator
17Β-hydroxyandrost-4-en-3-one heptanoateGenerator
17Β-hydroxyandrost-4-en-3-one heptanoic acidGenerator
Testosterone 17-enanthic acidGenerator
Testosterone heptanoic acidGenerator
Testosterone enanthic acidGenerator
17beta-Enanthoxyandrost-4-en-3-oneHMDB
17beta-Hydroxyandrost-4-en-3-one enanthateHMDB
4-Androsten-17beta-ol-3-one 17-enanthateHMDB
4-Androsten-3-one 17beta-enanthateHMDB
Androgyn l.a.HMDB
AndropositoryHMDB
AndrotardylHMDB
AtlatestHMDB
DEA no. 4000HMDB
DelatestHMDB
DePatestryeHMDB
depo-testro MedHMDB
DitateHMDB
DurathateHMDB
EveroneHMDB
Exten testHMDB
Malogen l.a.HMDB
Malogen l.a.200HMDB
Orquisteron-eHMDB
PrimotestoneHMDB
reposo TMDHMDB
TestanthateHMDB
TestateHMDB
TestenateHMDB
TestinonHMDB
TestoenantHMDB
TestonenantHMDB
Testosterone 17beta-heptanoateHMDB
Testosterone 17beta-heptanoic acidHMDB
Testosterone enantateHMDB
Testosterone heptoateHMDB
Testosterone heptoic acidHMDB
Testosterone heptylateHMDB
Testosterone oenanthateHMDB
TestostrovalHMDB
BTG Brand OF testosterone enanthateMeSH, HMDB
Jenapharm brand OF testosterone enanthateMeSH, HMDB
Rotexmedica brand OF testosterone enanthateMeSH, HMDB
Testosteron-depot jenapharmMeSH, HMDB
Pasadena brand OF testosterone enanthateMeSH, HMDB
Primoteston depotMeSH, HMDB
Rugby brand OF testosterone enanthateMeSH, HMDB
Testosteron depot-rotexmedicaMeSH, HMDB
Testosteron-depot eifelfangoMeSH, HMDB
Testrin p.a.MeSH, HMDB
Roberts brand OF testosterone enanthateMeSH, HMDB
eifelfango Brand OF testosterone enanthateMeSH, HMDB
Schering brand OF testosterone enanthateMeSH, HMDB
Theramed brand OF testosterone enanthateMeSH, HMDB
TheramexMeSH, HMDB
Chemical FormulaC26H40O3
Average Molecular Mass400.594 g/mol
Monoisotopic Mass400.298 g/mol
CAS Registry Number315-37-7
IUPAC Name(1S,2R,10R,11S,14S,15S)-2,15-dimethyl-5-oxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-6-en-14-yl heptanoate
Traditional Nameeverone
SMILES[H][C@@]12CC[C@H](OC(=O)CCCCCC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
InChI IdentifierInChI=1S/C26H40O3/c1-4-5-6-7-8-24(28)29-23-12-11-21-20-10-9-18-17-19(27)13-15-25(18,2)22(20)14-16-26(21,23)3/h17,20-23H,4-16H2,1-3H3/t20-,21-,22-,23-,25-,26-/m0/s1
InChI KeyVOCBWIIFXDYGNZ-IXKNJLPQSA-N
Chemical Taxonomy
Description belongs to the class of organic compounds known as steroid esters. Steroid esters are compounds containing a steroid moiety which bears a carboxylic acid ester group.
KingdomOrganic compounds
Super ClassLipids and lipid-like molecules
ClassSteroids and steroid derivatives
Sub ClassSteroid esters
Direct ParentSteroid esters
Alternative Parents
Substituents
  • Steroid ester
  • Androgen-skeleton
  • Androstane-skeleton
  • 3-oxosteroid
  • 3-oxo-delta-4-steroid
  • Oxosteroid
  • Delta-4-steroid
  • Cyclohexenone
  • Ketone
  • Carboxylic acid ester
  • Cyclic ketone
  • Monocarboxylic acid or derivatives
  • Carboxylic acid derivative
  • Organooxygen compound
  • Carbonyl group
  • Organic oxide
  • Organic oxygen compound
  • Hydrocarbon derivative
  • Aliphatic homopolycyclic compound
Molecular FrameworkAliphatic homopolycyclic compounds
External Descriptors
Biological Properties
StatusDetected and Not Quantified
OriginNot Available
Cellular LocationsNot Available
Biofluid LocationsNot Available
Tissue LocationsNot Available
PathwaysNot Available
ApplicationsNot Available
Biological RolesNot Available
Chemical RolesNot Available
Physical Properties
StateNot Available
AppearanceNot Available
Experimental Properties
PropertyValue
Melting PointNot Available
Boiling PointNot Available
SolubilityNot Available
Predicted Properties
PropertyValueSource
Water Solubility0.00046 g/LALOGPS
logP5.11ALOGPS
logP6.29ChemAxon
logS-5.9ALOGPS
pKa (Strongest Acidic)19.09ChemAxon
pKa (Strongest Basic)-4.8ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count2ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area43.37 ŲChemAxon
Rotatable Bond Count7ChemAxon
Refractivity116.61 m³·mol⁻¹ChemAxon
Polarizability49.2 ųChemAxon
Number of Rings4ChemAxon
Bioavailability1ChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Spectra
Spectra
Spectrum TypeDescriptionSplash KeyView
Predicted GC-MSPredicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positivesplash10-00dr-3479000000-622103246e9253c3578fSpectrum
Predicted GC-MSPredicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, PositiveNot AvailableSpectrum
Predicted GC-MSPredicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, PositiveNot AvailableSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Positivesplash10-0udi-2594800000-2fe5b98ade2c6812e290Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Positivesplash10-022i-5592000000-689f1cdb34f31cd98d15Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Positivesplash10-05mo-4490000000-d66a654ef39db2b12265Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Negativesplash10-0002-0149000000-2bec5293e6f91f7dbff5Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Negativesplash10-000i-0393000000-1dfe91f6ac9835af8928Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Negativesplash10-0a4r-2190000000-387672165ae5773ca45bSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Negativesplash10-0002-0109000000-867f88cb280a910aabe9Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Negativesplash10-01r2-1926000000-bc6e667c95b200d2ea91Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Negativesplash10-0a4l-9101000000-86eb2f6d2ad8f02878cdSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Positivesplash10-0udi-0040900000-fe6a5cf79e52e56acc46Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Positivesplash10-0229-1981100000-256658d507dc1dea4517Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Positivesplash10-06r6-5920000000-9787c0613d8215ab200bSpectrum
Toxicity Profile
Route of ExposureNot Available
Mechanism of ToxicityNot Available
MetabolismNot Available
Toxicity ValuesNot Available
Lethal DoseNot Available
Carcinogenicity (IARC Classification)Not Available
Uses/SourcesNot Available
Minimum Risk LevelNot Available
Health EffectsNot Available
SymptomsNot Available
TreatmentNot Available
Concentrations
Not Available
DrugBank IDDBSALT001030
HMDB IDHMDB0005814
FooDB IDFDB023772
Phenol Explorer IDNot Available
KNApSAcK IDNot Available
BiGG IDNot Available
BioCyc IDNot Available
METLIN IDNot Available
PDB IDNot Available
Wikipedia LinkTestosterone enanthate
Chemspider ID9045
ChEBI ID9464
PubChem Compound ID9416
Kegg Compound IDC08157
YMDB IDNot Available
ECMDB IDNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General References
1. Ulrich, Miroslav; Novacek, Alois; Stejskal, Frantisek. Testosterone enanthate. (1960), CS 95825 19600615 CAN 55:81895 AN 1961:81895
2. Ulrich, Miroslav; Novacek, Alois; Stejskal, Frantisek. Testosterone enanthate. (1960), CS 95825 19600615 CAN 55:81895 AN 1961:81895
3. Darby E, Anawalt BD: Male hypogonadism : an update on diagnosis and treatment. Treat Endocrinol. 2005;4(5):293-309.
4. Jarow JP, Zirkin BR: The androgen microenvironment of the human testis and hormonal control of spermatogenesis. Ann N Y Acad Sci. 2005 Dec;1061:208-20.
5. Gooren LJ, Bunck MC: Androgen replacement therapy: present and future. Drugs. 2004;64(17):1861-91.
6. Rogerson S, Weatherby RP, Deakin GB, Meir RA, Coutts RA, Zhou S, Marshall-Gradisnik SM: The effect of short-term use of testosterone enanthate on muscular strength and power in healthy young men. J Strength Cond Res. 2007 May;21(2):354-61.
7. Giuberti A, Manganini V, Picozzi SC, Vigano P, Strada GR: Complete genital prosthetization in patients treated with bilateral orchiectomy for metachronous testicular cancer. Arch Ital Urol Androl. 2007 Mar;79(1):26-9.
8. Schustack A, Meshiaj D, Waiss Z, Gotloib L: Intramuscular iron replenishment and replacement combined with testosterone enanthate in maintenance hemodialysis anemia: a follow-up of up to 8 years on 16 patients. Clin Nephrol. 1985 Jun;23(6):303-6.
9. Schubert M, Bullmann C, Minnemann T, Reiners C, Krone W, Jockenhovel F: Osteoporosis in male hypogonadism: responses to androgen substitution differ among men with primary and secondary hypogonadism. Horm Res. 2003;60(1):21-8.